Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Shares Issued (2016 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Shares Issued for 12 consecutive years, with $92000.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Shares Issued changed N/A year-over-year to $92000.0, compared with a TTM value of $92000.0 through Dec 2023, up 338.1%, and an annual FY2023 reading of $92000.0, up 338.1% over the prior year.
  • Shares Issued was $92000.0 for Q1 2023 at Alaunos Therapeutics, up from $21000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $100.0 million in Q2 2019 and bottomed at -$1000.0 in Q4 2021.
  • Average Shares Issued over 5 years is $9.2 million, with a median of $21000.0 recorded in 2022.
  • Peak annual rise in Shares Issued hit 25325.0% in 2021, while the deepest fall reached 100.25% in 2021.
  • Year by year, Shares Issued stood at $100.0 million in 2019, then crashed by 99.6% to $399000.0 in 2020, then crashed by 100.25% to -$1000.0 in 2021, then soared by 2200.0% to $21000.0 in 2022, then skyrocketed by 338.1% to $92000.0 in 2023.
  • Business Quant data shows Shares Issued for TCRT at $92000.0 in Q1 2023, $21000.0 in Q3 2022, and -$1000.0 in Q4 2021.